vTv Therapeutics (VTVT) Income from Non-Controlling Interests (2016 - 2025)

Historic Income from Non-Controlling Interests for vTv Therapeutics (VTVT) over the last 11 years, with Q3 2025 value amounting to -$1.6 million.

  • vTv Therapeutics' Income from Non-Controlling Interests fell 5581.84% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.9 million, marking a year-over-year decrease of 1149.22%. This contributed to the annual value of -$4.2 million for FY2024, which is 2576.98% up from last year.
  • According to the latest figures from Q3 2025, vTv Therapeutics' Income from Non-Controlling Interests is -$1.6 million, which was down 5581.84% from -$1.3 million recorded in Q2 2025.
  • vTv Therapeutics' Income from Non-Controlling Interests' 5-year high stood at -$233000.0 during Q2 2021, with a 5-year trough of -$2.4 million in Q4 2021.
  • For the 5-year period, vTv Therapeutics' Income from Non-Controlling Interests averaged around -$1.3 million, with its median value being -$1.2 million (2024).
  • Data for vTv Therapeutics' Income from Non-Controlling Interests shows a peak YoY increase of 8564.39% (in 2021) and a maximum YoY decrease of 60561.33% (in 2021) over the last 5 years.
  • Over the past 5 years, vTv Therapeutics' Income from Non-Controlling Interests (Quarter) stood at -$2.4 million in 2021, then skyrocketed by 44.7% to -$1.3 million in 2022, then grew by 28.4% to -$963000.0 in 2023, then rose by 16.61% to -$803000.0 in 2024, then crashed by 105.11% to -$1.6 million in 2025.
  • Its Income from Non-Controlling Interests stands at -$1.6 million for Q3 2025, versus -$1.3 million for Q2 2025 and -$1.1 million for Q1 2025.